Propanc Biopharma, Inc. (PPCB)

NASDAQ: PPCB · Real-Time Price · USD

0.9210

-0.0218 (-2.31%)

At close: Sep 11, 2026, 4:00 PM EDT

0.9010

-0.0200 (-2.17%)

After-hours: Sep 11, 2026, 7:38 PM EDT

Propanc Biopharma Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	-18.36	-58.92	-1.82	-2.66	-2.66	-2.03
Depreciation & Amortization	0.02	0.02	0.02	0.02	0.01	0
Other Amortization	0.31	0.3	0.29	0.2	0.05	0.14
Stock-Based Compensation	14.7	55.97	-	0.14	0.39	0.21
Other Operating Activities	-0.73	1.09	0.15	0.72	0.61	0.09
Change in Accounts Payable	-0.27	0.19	0.24	0.08	0.02	0.18
Change in Other Net Operating Assets	0.15	0.95	0.18	0.39	0.15	0.26
Operating Cash Flow	-4.17	-0.41	-0.94	-1.11	-1.44	-1.15
Operating Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Capital Expenditures	-0	-	-	-	-	-
Investing Cash Flow	-0	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Short-Term Debt Issued	-	0.54	0.84	0.59	0.77	0.33
Long-Term Debt Issued	-	0.34	0.22	-	-	-
Total Debt Issued	0.55	0.89	1.06	0.59	0.77	0.33
Short-Term Debt Repaid	-	-0.13	-0.14	-	-	-0.04
Total Debt Repaid	-1.07	-0.13	-0.14	-	-	-0.04
Net Debt Issued (Repaid)	-0.52	0.76	0.92	0.59	0.77	0.28
Issuance of Common Stock	4.31	-	0.02	0.52	0.72	0.78
Other Financing Activities	-0.2	-0.26	-	-	-	-
Financing Cash Flow	4.55	0.49	0.94	1.11	1.49	1.06

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Foreign Exchange Rate Adjustments	0.02	-0.09	0	-0	-0.05	0.02
Net Cash Flow	0.39	-0.01	0.01	0.01	0	-0.06

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Free Cash Flow	-4.18	-0.41	-0.94	-1.11	-1.44	-1.15
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-7.02	-2.55	-	-	-	-
Levered Free Cash Flow	4.78	12.9	-0.78	-0.51	-1.5	-0.77
Unlevered Free Cash Flow	4.88	12.95	-0.66	-0.38	-1.19	-0.63

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash Interest Paid	0.14	0.03	0.01	0	0	0.01
Change in Working Capital	-0.11	1.14	0.42	0.47	0.17	0.44